Hereditary transthyretin amyloidosis is associated with significant disease burden: analysis of the baseline characteristics of patients from the phase 3 study NEURO-TTR
25 August 2018 (11:00 - 16:00)
Organised by:
Abstract
About the speaker

University Hospital Henri Mondor, Creteil (France)
9 More presentations in this session
Access the full session
The Event
ESC Congress 2018
25 August 2018
11:00 CET

